drugset / Trial / NCT00547352

Study to Determine a Preference Between Sildenafil or Tadalafil Treatment for Problems Getting an Erection

NCT00547352

Phase 4 Completed 160 enrolled Eli Lilly and Company ICOS Corporation · collab
CrossoverOpen-label

Summary

To determine if men with problems getting and keeping an erection prefer treatment with tadalafil or sildenafil.

Timeline

Start
2004-06
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown
Comparator Tadalafil Small molecule 20 mg Oral

Indications